Vunakizumab (Anti-Human IL17A Recombinant Antibody) is a human IgGkappa monoclonal antibody that specifically targets and inhibits IL-17As receptor interaction, making it useful for researching autoimmune conditions such as psoriatic arthritis, ankylosing sp
CAS Number:
[1792181-33-9]
Target:
IL Receptor
* VAT and and shipping costs not included. Errors and price changes excepted